Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05174078
Other study ID # 21029
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 1, 2022
Est. completion date December 30, 2023

Study information

Verified date March 2023
Source Akron General Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes among Cleveland Clinic Akron General patients with chronic conditions. Findings from this study could guide doctors in deciding on appropriate nutrition and dietitian services for Cleveland Clinic patients.


Description:

Participants will receive healthy food items for 15 weeks and nutrition counseling and education to support chronic disease management at no cost. The healthy food items will consist of either medically-tailored pre-prepared meals, or a weekly produce box with recipes depending on the study arm. Participants must complete a baseline study visit, one nutritional counseling session via phone, 2 to 4 nutrition education videos, and a 16-week post-intervention study visit.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 70
Est. completion date December 30, 2023
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults 18 years of age or older who are patients at Akron General Center for Family Medicine - Have body mass index (BMI) equal to or greater that 30kg/m2 AND - Have at least one of the following diagnoses determined based on patients' problem list in the electronic medical record (EMR) and the international classification of diseases, 10th revision (ICD-10) codes: 1. Pre-type 2 diabetes mellitus 2. Type 2 diabetes mellitus 3. Hypertension - Have NOT participated in nutrition counseling at the University of Akron Nutrition Center within the past 6 months Exclusion Criteria: - Food allergies - Pregnant - No access to internet - Need English language interpretation - Currently participating in a structured weight loss program or using weight loss medications - Any condition that, in the Investigator's judgement, interferes with the ability to adhere to study requirements.

Study Design


Intervention

Other:
Medically-tailored meals
Medically tailored meals delivered to patients' homes for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.
Produce box and recipes
Weekly produce box and access to recipes via internet for 15 weeks AND one medical nutrition therapy session with a dietician + viewership of 2 to 4 nutrition education videos.

Locations

Country Name City State
United States Cleveland Clinic Akron General Akron Ohio

Sponsors (3)

Lead Sponsor Collaborator
Akron General Medical Center The Cleveland Clinic, The University of Akron

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in participants' body weight Percent weight loss From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Pre-type 2 diabetes mellitus: Change in number of medications Absolute change in number of medications From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Pre-type 2 diabetes mellitus: Change in medication dosage Percent change in medication dosage From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Pre-type 2 diabetes mellitus: Change in HbA1c Absolute change in HbA1c From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Type 2 diabetes mellitus: Change in number of medications Absolute change in number of medications From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Type 2 diabetes mellitus: Change in medication dosage Percent change in medication dosage From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Type 2 diabetes mellitus: Change in HbA1c Absolute change in HbA1c From baseline visit (W1) to 16 week visit and at 6 months and 12 months from baseline
Secondary Hypertension: Change in number of medications Absolute change in number of medications Baseline visit (W1) to 16 week visit
Secondary Hypertension: Change in medication dosage Percent change in medication dosage Baseline visit (W1) to 16 week visit
Secondary Receipt of healthy food items: The Hunger Vital Sign scale Values on the scale are: often true, sometimes true, and never true. A positive response to either or both of the first two values (often true, sometimes true) identifies households as being at risk for food insecurity Baseline visit (W1) to week 16 visit
Secondary Receipt of healthy food items: Eating at America's Table scale Each reported frequency is expressed as a daily average ranging from 0 to 5. The estimate of the daily number of Pyramid/MyPyramid servings is calculated as average daily frequency x the number of Pyramid/MyPyramid servings for the portion size, summed across all food groups. A higher score for fruits and vegetables indicates a better outcome. Baseline visit (W1) to week 16 visit
Secondary Receipt of healthy food items: Patient Health Questionnaire-8 Depression Scale Eight items, each of which is scored 0 to 3, providing a 0 to 24 severity score. Overall score is the sum of the 8 items. A score of 10 or greater is considered major depression, 20 or more is severe major depression. Baseline visit (W1) to week 16 visit
Secondary Nutrition Education: Healthy Eating and Weight Self-Efficacy Scale Values on the scale are: Strongly disagree, disagree, neutral, agree, and strongly agree. Responses of agree and strongly agree indicate a better outcome. Baseline visit (W1) to 16-week visit
Secondary Nutrition Education: Self-Efficacy for Managing Chronic Diseases Scale Six items, each of which is scored 0 to 10. Overall score is the mean of the 6 items. A higher score indicates a better outcome. Baseline visit (W1) to 16-week visit
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2